New Zealand markets open in 4 hours 26 minutes

MRNA Jan 2024 125.000 call

OPR - OPR Delayed price. Currency in USD
Add to watchlist
42.500.00 (0.00%)
As of 10:09AM EDT. Market open.
Full screen
Loading interactive chart…
  • Motley Fool

    Down 85%, Is There Any Hope for This Struggling Vaccine Stock?

    In the early days of the pandemic, if there was one coronavirus vaccine stock investors were betting on, it was Novavax (NASDAQ: NVAX). The biotech stock soared more than 2,700% in 2020 as it developed its vaccine candidate. In the same timeframe, Pfizer shares hardly budged.

  • Motley Fool

    Better Growth Stock: Moderna vs. Teladoc

    It may be a bit early to establish Moderna's (NASDAQ: MRNA) and Teladoc Health's (NYSE: TDOC) lasting growth stock status by looking at the past couple of years. Moderna launched the coronavirus vaccine as its first product in 2020 -- and vaccinated a good share of the population. Teladoc saw revenue and virtual medical visits soar in the triple digits as people opted to stick close to home.

  • Yahoo Finance Video

    Moderna's COVID booster faces supply limitations after manufacturing issues

    Health reporter Anjalee Khemlani examines the shortages Moderna is experiencing in its latest COVID-19 booster shot, while also discussing vaccination options ahead of this year's flu season